ClinicalTrials.Veeva

Menu

Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)

U

Università degli Studi di Ferrara

Status

Unknown

Conditions

COPD

Treatments

Device: Spirotiger®

Study type

Interventional

Funder types

Other

Identifiers

NCT01218295
IMTCOPD2

Details and patient eligibility

About

Many studies suggest that inspiratory muscles training by means of normocapnic hyperpnea improves exercise tolerance in healthy subjects. No information is available about the use of this training in COPD patients even if other methods (such as threshold loading and resistive loading) have been shown to be effective in terms of Inspiratory Muscle Function, Health-Related Quality of Life and Exercise Tolerance.

This study is designed to evaluate the effects of normocapnic hyperventilation by means of Spirotiger®, an instrument training the respiratory muscles, avoiding hypocapnia (using the methodology of isocapnic hyperpnoea)in COPD patients.

Enrollment

20 estimated patients

Sex

All

Ages

40 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • COPD patients. All patients are at stable state, free from an exacerbation from at least 3 months.

Exclusion criteria

  • COPD patients with a recent history of cardiovascular disease, neurologic disease and other diseases that would interfere with the training.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Respiratory muscle training
Experimental group
Description:
Patients assigned to this arm train the respiratory muscles by means of normocapnic hyperpnea.
Treatment:
Device: Spirotiger®

Trial contacts and locations

1

Loading...

Central trial contact

Luca Pomidori, PhD; Annalisa Cogo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems